NEW YORK (GenomeWeb) – Fluidigm today announced an approximately 19 percent decline in total revenue for the fourth quarter of 2016, among other preliminary financial results.

For the three months ended Dec. 31, the South San Francisco instrumentation firm expects between $24.7 million and $25.2 million in revenues, down from $30.7 million a year ago. On average, analysts are expecting total Q4 revenues of $26.3 million.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

CNN reports that researchers have tied a new variant to opioid addiction risk.

Organoids derived from patients' tumors may help determine what chemotherapy treatment patients would benefit from, according to New Scientist.

An initiative from GenomeAsia 100K hopes to increase the number of South Asians in genetic research, according to NBC News.

In Science this week: genomic analysis of ancient and modern horses indicates population turnover, and more.